TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs16897900
log Bayes Factor = 86.7495
Chromosome 6   position 30,755,893  (GRCh37) Explore rs16897900 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E10.9 Without complications
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
1.000 0.000 0.000
L40.5 Arthropathic psoriasis
1.000 0.000 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
L40 Psoriasis
1.000 0.000 0.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
T36-T50 Poisoning by drugs, medicaments and biological substances
1.000 0.000 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.000 1.000
E10.3 With ophthalmic complications
0.000 0.000 1.000
E16.2 Hypoglycaemia, unspecified
0.000 0.001 0.999
E16 Other disorders of pancreatic internal secretion
0.000 0.001 0.999
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.999 0.001 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.998 0.002 0.000
L40.0 Psoriasis vulgaris
0.993 0.007 0.000
T39.1 4-Aminophenol derivatives
0.992 0.008 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.010 0.990
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.988 0.012 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.987 0.013 0.000
E04 Other non-toxic goitre
0.000 0.019 0.981
E04.9 Non-toxic goitre, unspecified
0.000 0.022 0.978
E10.1 With ketoacidosis
0.000 0.025 0.975
T43.2 Other and unspecified antidepressants
0.969 0.031 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.969 0.031 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.958 0.042 0.000
E10.5 With peripheral circulatory complications
0.000 0.052 0.948
E10.4 With neurological complications
0.000 0.053 0.947
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.946 0.054 0.000
E14 Unspecified diabetes mellitus
0.000 0.060 0.940
T43.3 Phenothiazine antipsychotics and neuroleptics
0.939 0.061 0.000
E14.3 With ophthalmic complications
0.000 0.077 0.923
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.922 0.078 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.919 0.081 0.000
L40.1 Generalised pustular psoriasis
0.913 0.087 0.000
L40.8 Other psoriasis
0.901 0.099 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.897 0.103 0.000
E10.8 With unspecified complications
0.000 0.106 0.894
E50-E64 Other nutritional deficiencies
0.000 0.108 0.892
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.878 0.122 0.000
E10.6 With other specified complications
0.000 0.123 0.877
E10.0 With coma
0.000 0.132 0.868
T43.0 Tricyclic and tetracyclic antidepressants
0.861 0.139 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.859 0.141 0.000
E05.8 Other thyrotoxicosis
0.000 0.149 0.851
T43.6 Psychostimulants with abuse potential
0.837 0.163 0.000
T42.4 Benzodiazepines
0.828 0.172 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.823 0.176 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.185 0.815
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.800 0.200 0.000
T39.0 Salicylates
0.798 0.202 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.792 0.208 0.000
T42.1 Iminostilbenes
0.784 0.216 0.000
E07 Other disorders of thyroid
0.000 0.219 0.781
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.778 0.221 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.771 0.228 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.771 0.229 0.000
E55 Vitamin D deficiency
0.000 0.236 0.764
E10.2 With renal complications
0.000 0.237 0.763
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.761 0.239 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.760 0.240 0.000
E53 Deficiency of other B group vitamins
0.000 0.241 0.759
E14.6 With other specified complications
0.000 0.242 0.758
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.746 0.254 0.000
T45.0 Antiallergic and antiemetic drugs
0.743 0.257 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.743 0.257 0.000
T36 Poisoning by systemic antibiotics
0.729 0.271 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.271 0.728
T45.1 Antineoplastic and immunosuppressive drugs
0.728 0.272 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.724 0.276 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.720 0.280 0.000
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.717
L40.4 Guttate psoriasis
0.717 0.283 0.000
L40.3 Pustulosis palmaris et plantaris
0.717 0.283 0.000
L40.2 Acrodermatitis continua
0.717 0.283 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.717 0.283 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.717 0.283 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.717 0.283 0.000
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.283 0.717
E15 Nondiabetic hypoglycaemic coma
0.000 0.283 0.717
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.283 0.717
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.283 0.717
E16.4 Abnormal secretion of gastrin
0.000 0.283 0.717
E16.3 Increased secretion of glucagon
0.000 0.283 0.717
T43.9 Psychotropic drug, unspecified
0.717 0.283 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.717 0.283 0.000
T39.4 Antirheumatics, not elsewhere classified
0.715 0.285 0.000
T39.2 Pyrazolone derivatives
0.715 0.285 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.709 0.291 0.000
T42.3 Barbiturates
0.709 0.291 0.000
T42.2 Succinimides and oxazolidinediones
0.709 0.291 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.707 0.293 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.707 0.293 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.707 0.293 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.707 0.293 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.707 0.293 0.000
T44.0 Anticholinesterase agents
0.707 0.293 0.000
E07.9 Disorder of thyroid, unspecified
0.000 0.295 0.705
E04.8 Other specified non-toxic goitre
0.000 0.297 0.703
T47.0 Histamine H(2)-receptor antagonists
0.691 0.309 0.000
T50.8 Diagnostic agents
0.688 0.312 0.000
T50.7 Analeptics and opioid receptor antagonists
0.687 0.313 0.000
T50.5 Appetite depressants
0.687 0.313 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.687 0.313 0.000
T50.1 Loop [high-ceiling] diuretics
0.687 0.313 0.000
T50.0 Mineralocorticoids and their antagonists
0.687 0.313 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.684 0.316 0.000
E51 Thiamine deficiency
0.000 0.324 0.676
E58 Dietary calcium deficiency
0.000 0.325 0.675
E14.7 With multiple complications
0.000 0.326 0.674
E14.2 Withrenal complications
0.000 0.326 0.674
E14.0 With coma
0.000 0.326 0.674
E55.9 Vitamin D deficiency, unspecified
0.000 0.327 0.673
E14.1 With ketoacidosis
0.000 0.342 0.657
T48.5 Anti-common-cold drugs
0.657 0.343 0.000
E16.1 Other hypoglycaemia
0.000 0.347 0.652
E04.0 Non-toxic diffuse goitre
0.000 0.348 0.652
E14.5 With peripheral circulatory complications
0.000 0.355 0.645
E06 Thyroiditis
0.000 0.356 0.644
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.361 0.639
E63 Other nutritional deficiencies
0.000 0.361 0.639
E56 Other vitamin deficiencies
0.000 0.361 0.639
E50 Vitamin A deficiency
0.000 0.361 0.639
E60 Dietary zinc deficiency
0.000 0.361 0.639
E59 Dietary selenium deficiency
0.000 0.361 0.639
E54 Ascorbic acid deficiency
0.000 0.361 0.639
E52 Niacin deficiency [pellagra]
0.000 0.361 0.639
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.366 0.634
T50.4 Drugs affecting uric acid metabolism
0.630 0.370 0.000
E53.9 Vitamin B deficiency, unspecified
0.000 0.372 0.628
E14.4 With neurological complications
0.000 0.372 0.628
T47.4 Other laxatives
0.622 0.377 0.000
E14.8 With unspecified complications
0.000 0.382 0.618
T45.9 Primarily systemic and haematological agent, unspecified
0.616 0.384 0.000
T45.8 Other primarily systemic and haematological agents
0.616 0.384 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.616 0.384 0.000
T45.6 Fibrinolysis-affecting drugs
0.616 0.384 0.000
T45.4 Iron and its compounds
0.616 0.384 0.000
T45.3 Enzymes, not elsewhere classified
0.616 0.384 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.611 0.389 0.000
T46.1 Calcium-channel blockers
0.605 0.395 0.000
E53.8 Deficiency of other specified B group vitamins
0.000 0.398 0.602
M06.9 Rheumatoid arthritis, unspecified
0.000 0.407 0.593
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.590 0.409 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.590 0.409 0.000
T47.7 Emetics
0.590 0.409 0.000
T47.6 Antidiarrhoeal drugs
0.590 0.409 0.000
T47.5 Digestants
0.590 0.409 0.000
T47.3 Saline and osmotic laxatives
0.590 0.409 0.000
T47.2 Stimulant laxatives
0.590 0.409 0.000
E04.2 Non-toxic multinodular goitre
0.000 0.410 0.590
T42.0 Hydantoin derivatives
0.587 0.413 0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.414 0.586
E03.1 Congenital hypothyroidism without goitre
0.000 0.422 0.578
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.574 0.426 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.574 0.426 0.000
T48.4 Expectorants
0.574 0.426 0.000
T48.3 Antitussives
0.574 0.426 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.574 0.426 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.574 0.426 0.000
T48.0 Oxytocic drugs
0.574 0.426 0.000
T45.5 Anticoagulants
0.573 0.427 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.565 0.435 0.000
E07.1 Dyshormogenetic goitre
0.000 0.440 0.560
E07.0 Hypersecretion of calcitonin
0.000 0.440 0.560
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.440 0.560
T38.1 Thyroid hormones and substitutes
0.553 0.447 0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.451 0.549
E55.0 Rickets, active
0.000 0.452 0.548
E53.1 Pyridoxine deficiency
0.000 0.456 0.544
E53.0 Riboflavin deficiency
0.000 0.456 0.544
T46.4 Angiotensin-converting-enzyme inhibitors
0.536 0.463 0.000
T36.0 Penicillins
0.534 0.466 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.533 0.466 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.533 0.467 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.533 0.467 0.000
T46.7 Peripheral vasodilators
0.533 0.467 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.533 0.467 0.000
E40-E46 Malnutrition
0.000 0.469 0.531
E13 Other specified diabetes mellitus
0.000 0.469 0.530
E06.3 Autoimmune thyroiditis
0.000 0.475 0.524
T36.9 Systemic antibiotic, unspecified
0.522 0.477 0.000
T36.8 Other systemic antibiotics
0.522 0.477 0.000
T36.7 Antifungal antibiotics, systemically used
0.522 0.477 0.000
T36.6 Rifamycins
0.522 0.477 0.000
T36.5 Aminoglycosides
0.522 0.477 0.000
T36.4 Tetracyclines
0.522 0.477 0.000
T36.3 Macrolides
0.522 0.477 0.000
T36.2 Chloramphenicol group
0.522 0.477 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.522 0.477 0.000
T45.2 Vitamins, not elsewhere classified
0.521 0.478 0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.478 0.522
E51.2 Wernicke's encephalopathy
0.000 0.479 0.521
T38.9 Other and unspecified hormone antagonists
0.519 0.481 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.519 0.481 0.000
T38.7 Androgens and anabolic congeners
0.519 0.481 0.000
T38.5 Other oestrogens and progestogens
0.519 0.481 0.000
T38.4 Oral contraceptives
0.519 0.481 0.000
T38.2 Antithyroid drugs
0.519 0.481 0.000
T38.0 Glucocorticoids and synthetic analogues
0.519 0.481 0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.514 0.486 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.514 0.486 0.000
T37.5 Antiviral drugs
0.514 0.486 0.000
T37.4 Anthelminthics
0.514 0.486 0.000
T37.3 Other antiprotozoal drugs
0.514 0.486 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.514 0.486 0.000
T37.1 Antimycobacterial drugs
0.514 0.486 0.000
T37.0 Sulphonamides
0.514 0.486 0.000
T41.5 Therapeutic gases
0.514 0.486 0.000
T41.4 Anaesthetic, unspecified
0.514 0.486 0.000
T41.3 Local anaesthetics
0.514 0.486 0.000
T41.2 Other and unspecified general anaesthetics
0.514 0.486 0.000
T41.1 Intravenous anaesthetics
0.514 0.486 0.000
T41.0 Inhaled anaesthetics
0.514 0.486 0.000
T49.9 Topical agent, unspecified
0.514 0.486 0.000
T49.8 Other topical agents
0.514 0.486 0.000
T49.7 Dental drugs, topically applied
0.514 0.486 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.514 0.486 0.000
T49.5 Ophthalmological drugs and preparations
0.514 0.486 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.514 0.486 0.000
T49.3 Emollients, demulcents and protectants
0.514 0.486 0.000
T49.2 Local astringents and local detergents
0.514 0.486 0.000
T49.1 Antipruritics
0.514 0.486 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.514 0.486 0.000
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.487 0.513
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.505 0.495 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.504 0.496 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.502 0.498 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.500 0.500 0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.501 0.499
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.503 0.497
E61 Deficiency of other nutrient elements
0.000 0.505 0.495
E03.8 Other specified hypothyroidism
0.000 0.507 0.493
K90 Intestinal malabsorption
0.000 0.509 0.491
E51.9 Thiamine deficiency, unspecified
0.000 0.515 0.485
E51.8 Other manifestations of thiamine deficiency
0.000 0.515 0.485
E51.1 Beriberi
0.000 0.515 0.485
E06.4 Drug-induced thyroiditis
0.000 0.538 0.462
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.538 0.462
E06.0 Acute thyroiditis
0.000 0.538 0.462
E50.9 Vitamin A deficiency, unspecified
0.000 0.541 0.458
E50.8 Other manifestations of vitamin A deficiency
0.000 0.541 0.458
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.541 0.458
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.541 0.458
E50.5 Vitamin A deficiency with night blindness
0.000 0.541 0.458
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.541 0.458
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.541 0.458
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.541 0.458
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.541 0.458
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.541 0.458
E56.9 Vitamin deficiency, unspecified
0.000 0.541 0.458
E56.8 Deficiency of other vitamins
0.000 0.541 0.458
E56.1 Deficiency of vitamin K
0.000 0.541 0.458
E56.0 Deficiency of vitamin E
0.000 0.541 0.458
E63.9 Nutritional deficiency, unspecified
0.000 0.541 0.458
E63.8 Other specified nutritional deficiencies
0.000 0.541 0.458
E63.1 Imbalance of constituents of food intake
0.000 0.541 0.458
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.541 0.458
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.541 0.458
E64.8 Sequelae of other nutritional deficiencies
0.000 0.541 0.458
E64.3 Sequelae of rickets
0.000 0.541 0.458
E64.2 Sequelae of vitamin C deficiency
0.000 0.541 0.458
E64.1 Sequelae of vitamin A deficiency
0.000 0.541 0.458
E64.0 Sequelae of protein-energy malnutrition
0.000 0.541 0.458
E06.5 Other chronic thyroiditis
0.000 0.550 0.450
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.553 0.447
H36.0 Diabetic retinopathy
0.000 0.554 0.446
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.571 0.429
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.578 0.422
E06.1 Subacute thyroiditis
0.000 0.598 0.402
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.398 0.601 0.000
K90.9 Intestinal malabsorption, unspecified
0.000 0.606 0.393
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.001 0.609 0.391
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.619 0.381
E45 Retarded development following protein-energy malnutrition
0.000 0.619 0.381
E43 Unspecified severe protein-energy malnutrition
0.000 0.619 0.381
E42 Marasmic kwashiorkor
0.000 0.619 0.381
E41 Nutritional marasmus
0.000 0.619 0.381
E40 Kwashiorkor
0.000 0.619 0.381
E13.8 With unspecified complications
0.000 0.619 0.380
E13.7 With multiple complications
0.000 0.619 0.380
E13.6 With other specified complications
0.000 0.619 0.380
E13.5 With peripheral circulatory complications
0.000 0.619 0.380
E13.4 With neurological complications
0.000 0.619 0.380
E13.2 With renal complications
0.000 0.619 0.380
E13.1 With ketoacidosis
0.000 0.619 0.380
E13.0 With coma
0.000 0.619 0.380
E06.9 Thyroiditis, unspecified
0.000 0.631 0.369
E13.3 With ophthalmic complications
0.000 0.636 0.364
E61.9 Deficiency of nutrient element, unspecified
0.000 0.645 0.355
E61.8 Deficiency of other specified nutrient elements
0.000 0.645 0.355
E61.7 Deficiency of multiple nutrient elements
0.000 0.645 0.355
E61.6 Vanadium deficiency
0.000 0.645 0.355
E61.5 Molybdenum deficiency
0.000 0.645 0.355
E61.4 Chromium deficiency
0.000 0.645 0.355
E61.3 Manganese deficiency
0.000 0.645 0.355
E61.0 Copper deficiency
0.000 0.645 0.355
K90.3 Pancreatic steatorrhoea
0.000 0.648 0.352
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.648 0.352
K90.1 Tropical sprue
0.000 0.648 0.352
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.345 0.655 0.000
K90.8 Other intestinal malabsorption
0.000 0.657 0.343
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.658 0.341
E14.9 Without complications
0.000 0.667 0.333
E07.8 Other specified disorders of thyroid
0.001 0.671 0.328
E61.2 Magnesium deficiency
0.000 0.676 0.323
E04.1 Non-toxic single thyroid nodule
0.000 0.704 0.295
E65-E68 Obesity and other hyperalimentation
0.000 0.711 0.289
M07.39 Other psoriatic arthropathies (Site unspecified)
0.275 0.725 0.000
E44.1 Mild protein-energy malnutrition
0.000 0.727 0.273
E44.0 Moderate protein-energy malnutrition
0.000 0.727 0.273
M07.3 Other psoriatic arthropathies
0.268 0.731 0.001
M07.30 Other psoriatic arthropathies (Multiple sites)
0.267 0.733 0.000
E61.1 Iron deficiency
0.000 0.736 0.263
T40.5 Cocaine
0.260 0.740 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.247 0.752 0.000
T40.8 Lysergide [LSD]
0.247 0.752 0.000
T40.7 Cannabis (derivatives)
0.247 0.752 0.000
T40.3 Methadone
0.247 0.752 0.000
T40.1 Heroin
0.247 0.752 0.000
T40.0 Opium
0.247 0.752 0.000
M06 Other rheumatoid arthritis
0.001 0.758 0.241
T40.6 Other and unspecified narcotics
0.228 0.772 0.000
E13.9 Without complications
0.000 0.772 0.227
L40-L45 Papulosquamous disorders
0.224 0.775 0.001
N23 Unspecified renal colic
0.225 0.775 0.000
H36 Retinal disorders in diseases classified elsewhere
0.000 0.780 0.220
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.208 0.791 0.001
E67 Other hyperalimentation
0.000 0.792 0.207
E68 Sequelae of hyperalimentation
0.000 0.792 0.207
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.205 0.794 0.001
E46 Unspecified protein-energy malnutrition
0.001 0.805 0.194
M07.38 Other psoriatic arthropathies (Other)
0.192 0.807 0.001
M07.33 Other psoriatic arthropathies (Forearm)
0.192 0.807 0.001
M07.32 Other psoriatic arthropathies (Upper arm)
0.192 0.807 0.001
M07.31 Other psoriatic arthropathies (Shoulder region)
0.192 0.807 0.001
M07.36 Other psoriatic arthropathies (Lower leg)
0.192 0.807 0.001
M06.4 Inflammatory polyarthropathy
0.000 0.815 0.185
M07.34 Other psoriatic arthropathies (Hand)
0.183 0.816 0.001
L41 Parapsoriasis
0.175 0.824 0.001
M06.8 Other specified rheumatoid arthritis
0.001 0.827 0.173
M06.2 Rheumatoid bursitis
0.001 0.827 0.173
M06.1 Adult-onset Still's disease
0.001 0.827 0.173
T40.4 Other synthetic narcotics
0.167 0.832 0.000
M06.3 Rheumatoid nodule
0.001 0.833 0.166
L44 Other papulosquamous disorders
0.161 0.839 0.001
L45 Papulosquamous disorders in diseases classified elsewhere
0.161 0.839 0.001
H36.8 Other retinal disorders in diseases classified elsewhere
0.000 0.842 0.158
M06.40 Inflammatory polyarthropathy (Multiple sites)
0.000 0.849 0.150
E67.8 Other specified hyperalimentation
0.000 0.851 0.149
E67.3 Hypervitaminosis D
0.000 0.851 0.149
E67.2 Megavitamin-B6 syndrome
0.000 0.851 0.149
E67.1 Hypercarotenaemia
0.000 0.851 0.149
E67.0 Hypervitaminosis A
0.000 0.851 0.149
N20-N23 Urolithiasis
0.147 0.853 0.000
M06.0 Seronegative rheumatoid arthritis
0.000 0.858 0.142
L41.1 Pityriasis lichenoides chronica
0.140 0.859 0.000
L42 Pityriasis rosea
0.140 0.859 0.001
N20 Calculus of kidney and ureter
0.139 0.861 0.000
N20.0 Calculus of kidney
0.138 0.862 0.000
M07 Psoriatic and enteropathic arthropathies
0.114 0.865 0.020
M06.48 Inflammatory polyarthropathy (Other)
0.000 0.867 0.133
M06.47 Inflammatory polyarthropathy (Ankle and foot)
0.000 0.867 0.133
M06.46 Inflammatory polyarthropathy (Lower leg)
0.000 0.867 0.133
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)
0.000 0.867 0.133
M06.44 Inflammatory polyarthropathy (Hand)
0.000 0.867 0.133
M06.43 Inflammatory polyarthropathy (Forearm)
0.000 0.867 0.133
M06.42 Inflammatory polyarthropathy (Upper arm)
0.000 0.867 0.133
M06.41 Inflammatory polyarthropathy (Shoulder region)
0.000 0.867 0.133
M06.34 Rheumatoid nodule (Hand)
0.000 0.869 0.131
L41.9 Parapsoriasis, unspecified
0.126 0.874 0.001
L41.8 Other parapsoriasis
0.126 0.874 0.001
L41.5 Retiform parapsoriasis
0.126 0.874 0.001
L41.4 Large plaque parapsoriasis
0.126 0.874 0.001
L41.3 Small plaque parapsoriasis
0.126 0.874 0.001
L41.2 Lymphomatoid papulosis
0.126 0.874 0.001
L41.0 Pityriasis lichenoides et varioliformis acuta
0.126 0.874 0.001
M06.19 Adult-onset Still's disease (Site unspecified)
0.001 0.875 0.124
M06.18 Adult-onset Still's disease (Other)
0.001 0.875 0.124
M06.17 Adult-onset Still's disease (Ankle and foot)
0.001 0.875 0.124
M06.16 Adult-onset Still's disease (Lower leg)
0.001 0.875 0.124
M06.15 Adult-onset Still's disease (Pelvic region and thigh)
0.001 0.875 0.124
M06.14 Adult-onset Still's disease (Hand)
0.001 0.875 0.124
M06.13 Adult-onset Still's disease (Forearm)
0.001 0.875 0.124
M06.12 Adult-onset Still's disease (Upper arm)
0.001 0.875 0.124
M06.11 Adult-onset Still's disease (Shoulder region)
0.001 0.875 0.124
M06.10 Adult-onset Still's disease (Multiple sites)
0.001 0.875 0.124
M06.29 Rheumatoid bursitis (Site unspecified)
0.001 0.875 0.124
M06.28 Rheumatoid bursitis (Other)
0.001 0.875 0.124
M06.27 Rheumatoid bursitis (Ankle and foot)
0.001 0.875 0.124
M06.26 Rheumatoid bursitis (Lower leg)
0.001 0.875 0.124
M06.25 Rheumatoid bursitis (Pelvic region and thigh)
0.001 0.875 0.124
M06.24 Rheumatoid bursitis (Hand)
0.001 0.875 0.124
M06.23 Rheumatoid bursitis (Forearm)
0.001 0.875 0.124
M06.22 Rheumatoid bursitis (Upper arm)
0.001 0.875 0.124
M06.21 Rheumatoid bursitis (Shoulder region)
0.001 0.875 0.124
M06.20 Rheumatoid bursitis (Multiple sites)
0.001 0.875 0.124
M06.89 Other specified rheumatoid arthritis (Site unspecified)
0.001 0.875 0.124
M06.88 Other specified rheumatoid arthritis (Other)
0.001 0.875 0.124
M06.87 Other specified rheumatoid arthritis (Ankle and foot)
0.001 0.875 0.124
M06.86 Other specified rheumatoid arthritis (Lower leg)
0.001 0.875 0.124
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)
0.001 0.875 0.124
M06.84 Other specified rheumatoid arthritis (Hand)
0.001 0.875 0.124
M06.83 Other specified rheumatoid arthritis (Forearm)
0.001 0.875 0.124
M06.82 Other specified rheumatoid arthritis (Upper arm)
0.001 0.875 0.124
M06.81 Other specified rheumatoid arthritis (Shoulder region)
0.001 0.875 0.124
M06.80 Other specified rheumatoid arthritis (Multiple sites)
0.001 0.875 0.124
M06.49 Inflammatory polyarthropathy (Site unspecified)
0.000 0.876 0.124
E65 Localised adiposity
0.001 0.878 0.122
M06.39 Rheumatoid nodule (Site unspecified)
0.001 0.880 0.119
M06.38 Rheumatoid nodule (Other)
0.001 0.880 0.119
M06.36 Rheumatoid nodule (Lower leg)
0.001 0.880 0.119
M06.35 Rheumatoid nodule (Pelvic region and thigh)
0.001 0.880 0.119
M06.33 Rheumatoid nodule (Forearm)
0.001 0.880 0.119
M06.31 Rheumatoid nodule (Shoulder region)
0.001 0.880 0.119
M06.32 Rheumatoid nodule (Upper arm)
0.000 0.883 0.116
M06.37 Rheumatoid nodule (Ankle and foot)
0.000 0.884 0.116
M06.09 Seronegative rheumatoid arthritis (Site unspecified)
0.000 0.884 0.116
L44.9 Papulosquamous disorder, unspecified
0.115 0.884 0.001
L44.8 Other specified papulosquamous disorders
0.115 0.884 0.001
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.115 0.884 0.001
L44.3 Lichen ruber moniliformis
0.115 0.884 0.001
L44.2 Lichen striatus
0.115 0.884 0.001
L44.1 Lichen nitidus
0.115 0.884 0.001
L44.0 Pityriasis rubra pilaris
0.115 0.884 0.001
N20.1 Calculus of ureter
0.109 0.891 0.000
N20.9 Urinary calculus, unspecified
0.107 0.893 0.000
N22 Calculus of urinary tract in diseases classified elsewhere
0.105 0.895 0.000
M06.30 Rheumatoid nodule (Multiple sites)
0.001 0.896 0.104
M06.08 Seronegative rheumatoid arthritis (Other)
0.000 0.898 0.102
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)
0.000 0.898 0.102
M06.04 Seronegative rheumatoid arthritis (Hand)
0.000 0.898 0.102
M06.03 Seronegative rheumatoid arthritis (Forearm)
0.000 0.898 0.102
M06.02 Seronegative rheumatoid arthritis (Upper arm)
0.000 0.898 0.102
M06.06 Seronegative rheumatoid arthritis (Lower leg)
0.000 0.900 0.099
T40.2 Other opioids
0.099 0.901 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.902 0.098
M07.6 Other enteropathic arthropathies
0.082 0.903 0.015
M07.5 Arthropathy in ulcerative colitis
0.082 0.903 0.015
M07.4 Arthropathy in Crohn's disease [regional enteritis]
0.082 0.903 0.015
M07.2 Psoriatic spondylitis
0.082 0.903 0.015
M07.1 Arthritis mutilans
0.082 0.903 0.015
M07.0 Distal interphalangeal psoriatic arthropathy
0.082 0.903 0.015
Z91.5 Personal history of self-harm
0.094 0.906 0.000
E11.3 With ophthalmic complications
0.000 0.906 0.094
E20-E35 Disorders of other endocrine glands
0.080 0.907 0.013
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)
0.001 0.911 0.089
M06.01 Seronegative rheumatoid arthritis (Shoulder region)
0.001 0.911 0.089
E23 Hypofunction and other disorders of pituitary gland
0.087 0.912 0.001
M06.00 Seronegative rheumatoid arthritis (Multiple sites)
0.000 0.916 0.084
E23.7 Disorder of pituitary gland, unspecified
0.082 0.918 0.000
E23.0 Hypopituitarism
0.081 0.918 0.000
E11.8 With unspecified complications
0.000 0.922 0.077
E26 Hyperaldosteronism
0.071 0.923 0.006
E23.6 Other disorders of pituitary gland
0.077 0.923 0.001
N22.8 Calculus of urinary tract in other diseases classified elsewhere
0.076 0.924 0.000
N22.0 Calculus of urinary tract in schistosomiasis [bilharziasis]
0.076 0.924 0.000
E23.2 Diabetes insipidus
0.074 0.925 0.000
E22 Hyperfunction of pituitary gland
0.069 0.926 0.006
E20 Hypoparathyroidism
0.065 0.927 0.008
L43 Lichen planus
0.070 0.928 0.002
E11.7 With multiple complications
0.000 0.930 0.070
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)
0.059 0.930 0.011
M07.08 Distal interphalangeal proriatic arthropathy-Other
0.059 0.930 0.011
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)
0.059 0.930 0.011
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg
0.059 0.930 0.011
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh
0.059 0.930 0.011

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.